Nuclear Imaging Equipment Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Summary
GlobalData's Medical Devices sector report, “Nuclear Imaging Equipment Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2023 Update provides comprehensive information about the Nuclear Imaging Equipment pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.
Nuclear Imaging Equipment makes use of radioactive substances (also called as nuclear medicine or radiopharmaceuticals) that are inserted into the body orally or intravenously. These systems capture the radiations emitted by radiopharmaceuticals to create images of the structures and activities inside the human body. These images enable physicians to look inside a human body to help determine the cause of an illness or injury and provide an accurate diagnosis.
Note:Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.
Scope
Extensive coverage of the Nuclear Imaging Equipment under development
The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
The report reviews the major players involved in the development of Nuclear Imaging Equipment and list all their pipeline projects
The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
The report provides key clinical trial data of ongoing trials specific to pipeline products
Recent developments in the segment / industry
Reasons to Buy
The report enables you to -
Formulate significant competitor information, analysis, and insights to improve R&D strategies
Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
Identify and understand important and diverse types of Nuclear Imaging Equipment under development
Develop market-entry and market expansion strategies
Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
In-depth analysis of the product’s current stage of development, territory and estimated launch date
1 About GlobalData
2 Table of Contents
2.1 List of Tables
2.2 List of Figures
3 Introduction
3.1 Nuclear Imaging Equipment Overview
4 Products under Development
4.1 Nuclear Imaging Equipment - Pipeline Products by Stage of Development
4.2 Nuclear Imaging Equipment - Pipeline Products by Segment
4.3 Nuclear Imaging Equipment - Pipeline Products by Territory
4.4 Nuclear Imaging Equipment - Pipeline Products by Regulatory Path
4.5 Nuclear Imaging Equipment - Pipeline Products by Estimated Approval Date
6.45.1 ZumaTek, Inc. Pipeline Products & Ongoing Clinical Trials Overview
7 Nuclear Imaging Equipment- Recent Developments
7.1 Nov 23, 2023: Curasight Announces Interim Report January – September 2023
7.2 Nov 22, 2023: Oxford Instruments Brings Hill & Smith CFO Hannah Nichols to Board
7.3 Nov 22, 2023: Oxford Instruments Names Hill & Smith CFO to Its Board
7.4 Nov 22, 2023: Oxford Instruments Announces Appointment of Independent Non-Executive Director
7.5 Nov 22, 2023: PET Positivity After Two Cycles of ABVD Is Associated with a Worse Outcome in Localised Hodgkin Lymphoma Although Intensification with BEACOPPesc Is Safe
7.6 Nov 20, 2023: Concord Medical Schedules 2023 Annual Meeting of Shareholders
7.7 Nov 14, 2023: Oxford Instruments Reports Interim Results for the Six Months to 30 September 2023
7.8 Nov 09, 2023: Hyperfine Reports Third Quarter 2023 Financial Results
7.9 Nov 08, 2023: Synlab Announces Continued Strong Performance in the Third Quarter of 2023
7.1 Nov 08, 2023: Star Equity Holdings Announces 2023 Third Quarter Financial Results
7.11 Oct 31, 2023: GE HealthCare Reports Third Quarter 2023 Financial Results
7.12 Oct 26, 2023: Shanghai United Imaging Healthcare Receives Additional 510(K) Clearance For uMI Panorama
7.13 Oct 24, 2023: Cinven Acquires Majority Stake in Synlab AG
7.14 Oct 19, 2023: Hyperfine to Announce Third Quarter Financial Results on November 9, 2023
7.15 Oct 16, 2023: Bracco Diagnostics Showcases Innovation and Collaborative Vision at RSNA 2023 Annual Meeting
7.16 Oct 11, 2023: General De Equipment for Medical Imaging Receives 510(K) Clearance For CareMiBrain
7.17 Oct 07, 2023: UK Launches Its First National Total-Body PET Platform for Drug Discovery
7.18 Oct 04, 2023: Positron Corporation Announces Attrius PET System Sale
7.19 Oct 02, 2023: Oxford Instruments Welcomes New Chief Executive, Richard Tyson
7.2 Sep 28, 2023: Canon Medical Systems Obtains Additional 510(k) Clearance for Cartesion Prime
7.21 Sep 22, 2023: Concord Medical Reports Financial Results for the First Half of 2023
7.22 Sep 21, 2023: United Imaging Healthcare debuts Next-Generation PET/CT Systems, the uMI Panorama Family, and the Integrated Molecular Technology Platform at EANM
7.23 Sep 12, 2023: Kromek Detectors in New Spectrum Dynamics Scanner
7.24 Sep 11, 2023: Positron and Ochsner Clinic to initiate study of imaging device
7.25 Sep 07, 2023: United Imaging Confirms Installation of Country's First uMI Panorama at Huntsman Cancer Institute
7.26 Sep 07, 2023: AURA 10 FDA approved
7.27 Sep 07, 2023: Philips Reaches Resolution of US Economic Loss Litigation
7.28 Sep 05, 2023: Siemens Healthineers Expands Production Site in Rudolstadt, Germany and Creates New Jobs
7.29 Aug 24, 2023: Curasight Announces Interim Report January - June 2023
7.3 Aug 23, 2023: Xeos Receives 510(k) Clearance for Aura 10 PET/CT Specimen Imager
7.31 Aug 14, 2023: Shanghai United Imaging Healthcare Receives Additional 510(k) Clearance for uMI Panorama
7.32 Aug 14, 2023: Hyperfine Reports Second Quarter 2023 Financial Results
7.33 Jul 31, 2023: Positron Orders Six Attrius PET Systems and Components from Neusoft Positron Medical Systems
7.34 Jul 28, 2023: CoxHealth and Philips partner on virtual care solution
7.35 Jul 24, 2023: Siemens Medical Solutions Receives FDA 510(K) Clearance for Biograph Vision.X Edge
7.36 Jul 24, 2023: Siemens Medical Solutions Receives FDA 510(K) Clearance for Biograph Vision.X
7.37 Jun 27, 2023: Genomics- and Image-Guided Subtyping Refines Characterization of Alzheimer’s Disease
7.38 Jun 25, 2023: United Imaging Introduces Next-Generation Pet/CT Systems and Integrated Molecular Technology Platform at SNMMI
7.39 Jun 25, 2023: SNMMI and IAC Collaborate on New Radiopharmaceutical Therapy Accreditation Program
7.4 Jun 13, 2023: Oxford Instruments Announcement of unaudited full-year results for the 12 months to 31 March 2023
7.41 Jun 13, 2023: Oxford Instruments Announces Preliminary Results for the 12 Months to 31 March 2023
7.42 May 30, 2023: Siemens Healthineers receives 510(k) clearance for Symbia Pro.Specta
7.43 May 17, 2023: United Imaging unveils a full portfolio of products at CMEF 2023, Highlighting Its AI Capabilities across Modalities
7.44 May 15, 2023: Star Equity Holdings announces 2023 first quarter financial results
7.45 May 12, 2023: GE HealthCare Introduces Innovations to Improve Radiation Therapy Efficiency and Precision Care at the European Society for Therapeutic Radiology and Oncology 2023 Congress
7.46 May 11, 2023: Hyperfine reports first quarter 2023 financial results
7.47 May 10, 2023: SYNLAB reports strong start to fiscal year 2023
7.48 May 09, 2023: GE HealthCare Names James Saccaro Vice President and Chief Financial Officer
7.49 May 07, 2023: Spectrum Dynamics receives 510(k) clearance for VERITON CT 300 Series Digital SPECT/CT System (VERITON CT 316/364)
7.5 May 07, 2023: Spectrum Dynamics receives 510(k) clearance for VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
7.51 Apr 28, 2023: Siemens to announce second quarter results FY 2023
7.52 Apr 20, 2023: Hyperfine to announce first quarter financial results on May 11, 2023
7.53 Apr 19, 2023: Concord Medical Files 2022 Annual Report on Form 20-F
7.54 Apr 13, 2023: Ian Barkshire to retire and Richard Tyson to be appointed as Chief Executive Officer of Oxford Instruments
7.55 Apr 06, 2023: TTG Imaging Solutions announces first U.S. MiE ANCORIS installation
7.56 Mar 21, 2023: Hyperfine Reports Fourth Quarter and Full Year 2022 Financial Results
7.57 Mar 15, 2023: Curasight Notice of Annual General Meeting 2023
7.58 Mar 15, 2023: SYNLAB Announces Extension of the appointment of Mathieu Floreani as CEO and Sami Badarani as CFO
7.59 Mar 06, 2023: Hyperfine to Announce Fourth Quarter and Full Year 2022 Financial Results on March 21, 2023
7.6 Mar 01, 2023: Positron Corporation enters into agreement with Ochsner Clinic Foundation for clinical study of its New “Affinity PET-CT 4D” Device
7.61 Feb 15, 2023: GE HealthCare recalls nuclear medicine 600/800 series systems for risk of detector fall that may injure patients
7.62 Feb 14, 2023: Siemens Limited announces Q1 FY 2023 results; 80% increase in PAT from continuing operations
7.63 Feb 08, 2023: Siemens Announces Earnings Release and Financial Results for the First Quarter of Fiscal Year 2023
7.64 Feb 08, 2023: Hyperfine Announces Brett Hale as New Chief Administrative Officer & Chief Financial Officer
7.66 Feb 01, 2023: Canon posts record revenues in medical business unit
7.67 Jan 30, 2023: Philips to lay off 6,000 employees in drive to improve profitability
7.68 Jan 30, 2023: GE HealthCare Reports Fourth Quarter and Full Year 2022 Financial Results
7.69 Jan 23, 2023: The Athinoula A. Martinos Center for Biomedical Imaging at Massachusetts General Hospital selects Cubresa’s BrainPET Insert System to support brain research studies
7.7 Jan 17, 2023: GE HealthCare to Announce Fourth Quarter and Full Year 2022 Results on January 30, 2023
7.71 Jan 10, 2023: GE HealthCare Announces Preliminary Fourth Quarter and Full Year 2022 Revenue Results; Introduces 2023 Outlook
7.72 Jan 03, 2023: Siemens Healthineers receives an additional 510(k) clearance for Biograph Vision Quadra PET/CT System
7.73 Dec 20, 2022: Positron announces plans for clinical study of its new “Affinity PET-CT 4D” nuclear imaging device
7.74 Dec 06, 2022: Associated Medical Professionals of NY Adds Robert Creaven as Chief Operating Officer
8 Appendix
8.1 Methodology
8.2 About GlobalData
8.3 Contact Us
8.4 Disclaimer
2.1 List of Tables
Table 1: Nuclear Imaging Equipment - Pipeline Products by Stage of Development
Table 2: Nuclear Imaging Equipment - Pipeline Products by Segment
Table 3: Nuclear Imaging Equipment - Pipeline Products by Territory
Table 99: Radialis PET Camera - Product Description
Table 100: Radialis Medical Inc - Ongoing Clinical Trials Overview
Table 101: Radialis PET Camera - A Pilot Study to Evaluate Low-Dose Positron Emission Mammography Imaging in Visualization and Characterization of Suspicious Breast Abnormalities
Table 136: Brain-Dedicated PET System - Product Status
Table 137: Brain-Dedicated PET System - Product Description
Table 138: Breast-Dedicated PET System - Product Status
Table 139: Breast-Dedicated PET System - Product Description
Table 140: Dual Panel PET Scanner - Product Status
Table 141: Dual Panel PET Scanner - Product Description
Table 142: Dual-isotope Positron Emitting Tomography System - Product Status
Table 143: Dual-isotope Positron Emitting Tomography System - Product Description
Table 144: Next Generation TOF-PET System - Product Status
Table 145: Next Generation TOF-PET System - Product Description
Table 146: PET Sensitivity Enhancing System - Product Status
Table 147: PET Sensitivity Enhancing System - Product Description
Table 148: PET System - Product Status
Table 149: PET System - Product Description
Table 150: Stanford University - Ongoing Clinical Trials Overview
Table 151: Breast-Dedicated PET System - Pilot Study of a Breast-dedicated PET Camera with 1 Millimeter Spatial Resolution
Table 152: Brain-Dedicated PET System - Pilot Study for Simultaneous PET-MR Imaging of Covid-19 Associated Neurological Complications Using a Brain Dedicated PET Insert